Mirae Asset Global ETFs Holdings’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$200K Sell
17,554
-693
-4% -$7.51K ﹤0.01% 2364
2025
Q4
$234K Buy
18,247
+439
+2% +$5.42K ﹤0.01% 2274
2025
Q3
$199K Sell
17,808
-3,457
-16% -$33.4K ﹤0.01% 2323
2025
Q2
$211K Sell
21,265
-1,723
-7% -$16.9K ﹤0.01% 2257
2025
Q1
$216K Buy
22,988
+1,020
+5% +$10.7K ﹤0.01% 2284
2024
Q4
$201K Buy
21,968
+969
+5% +$7.13K ﹤0.01% 2384
2024
Q3
$163K Buy
20,999
+1,475
+8% +$10.7K ﹤0.01% 2472
2024
Q2
$118K Buy
+19,524
New +$120K ﹤0.01% 2494

Other funds holding ANGO

Mirae Asset Global ETFs Holdings's ANGO Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its AngioDynamics (ANGO) stake by 3.8% in Q1 2026, selling an estimated $7.51K and leaving 17,554 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

Mirae Asset Global ETFs Holdings first reported a position in ANGO in Q2 2024 and has held it in 8 quarters since. The position peaked at $234K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 17,554 shares of AngioDynamics worth $200K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 693 AngioDynamics shares in Q1 2026, an estimated $7.51K.
  • AngioDynamics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2364 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in AngioDynamics in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's AngioDynamics position peaked at $234K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.